Structural analysis of recombinant AAV vector genomes at single-molecule resolution
David Rouleau1, Dimpal Lata1, Serena Dollive1
1Oxford Biomedica (US) LLC, Bedford, Massachusetts, United States of America.
Plos One
|July 30, 2026
Summary
A new pipeline precisely classifies individual adeno-associated virus (AAV) genomes and their structural variants. This tool enhances AAV vector safety and efficacy by detailing genome heterogeneity for improved therapeutic design.
Area of Science:
- Molecular Biology
- Gene Therapy
- Bioinformatics
Background:
- Recombinant adeno-associated virus (AAV) vectors are crucial for in vivo gene therapy.
- Genome heterogeneity in AAV vectors poses a significant safety concern.
- Accurate characterization of AAV genome structure is essential for therapeutic development.
Purpose of the Study:
- To develop and validate a novel computational pipeline for analyzing AAV genome heterogeneity.
- To enable precise classification of individual AAV genomes and their structural variants.
- To provide insights into sequence and structural features influencing AAV genome diversity.
Main Methods:
- Development of a long-read, read-level analysis pipeline utilizing PacBio sequencing data.
- The pipeline integrates a tiling step for read alignment and a parsing step using formal grammar for classification.
- Classification into five structural categories: expected, truncated, snapback, truncated snapback, and others, with detailed annotation.
Main Results:
- The pipeline achieved high accuracy in classifying AAV genome structures from both single-stranded and self-complementary vectors.
- Analysis revealed distinct genome structure patterns, with the majority classified as expected full-length species.
- Snapback genome breakpoints often clustered at specific sites, suggesting roles for secondary structures and other mechanisms.
Conclusions:
- The developed pipeline offers a comprehensive framework for evaluating AAV genome diversity at single-vector resolution.
- Insights into AAV genome heterogeneity can guide vector design and production for improved safety and efficacy.
- The method demonstrates robustness against sequencing errors, enhancing its utility for AAV therapeutic development.

